AKZA Stock Analysis: Akzo Nobel | AS
Specialty Chemicals | AS, Netherlands | Market Cap: 10.415m EUR | 12M Return: -1.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 30.8M
EPS Trend: 76.5%
Qual. Beats: 0
Rev. Trend: -84.2%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Akzo Nobel N.V. is a Dutch producer of paints and coatings, headquartered in Amsterdam and operating globally through two segments: Decorative Paints and Performance Coatings. Its Decorative Paints arm offers paints, enamels, varnishes, and surface preparation products, along with mixing machines, color concepts, and applicator training, while Performance Coatings supplies engineered coatings with functional properties such as corrosion and fouling control, fire protection, and scratch resistance for ships, cars, aircraft, yachts, architectural components, consumer goods, and oil and gas facilities.
The company markets its products under a broad brand portfolio that includes Dulux, Sikkens, International, Interpon, Hammerite, Pintuco, Flexa, and Taubmans, serving end markets such as construction, infrastructure, energy, packaging, shipbuilding, and general industrial applications. Akzo Nobel traces its origins to 1646 and adopted its current name in 1994 following the merger that formed Akzo Nobel.
As a specialty chemicals business within the broader Materials sector, Akzo Nobel combines a consumer-facing decorative paints franchise with a higher-specification industrial coatings portfolio, where brand equity, technical service, and product performance certification typically drive competitive positioning. Earnings are closely linked to global construction and renovation activity, automotive and aerospace production cycles, and industrial maintenance spending.
- Decorative paints pricing and volumes drive margin recovery
- Raw material costs including titanium dioxide pressure gross margins
- Performance coatings demand tied to automotive and industrial cycles
| Net Income: 621.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.60 > 1.0 |
| NWC/Revenue: 31.62% < 20% (prev 16.22%; Δ 15.40% < -1%) |
| CFO/TA 0.06 > 3% & CFO 956.0m > Net Income 621.0m |
| Net Debt (3.35b) to EBITDA (1.59b): 2.11 < 3 |
| Current Ratio: 1.72 > 1.5 & < 3 |
| Outstanding Shares: last quarter (171.2m) vs 12m ago -0.80% < -2% |
| Gross Margin: 40.07% > 18% (prev 40.23%; Δ -0.16% > 0.5%) |
| Asset Turnover: 65.47% > 50% (prev 71.95%; Δ -6.47% > 0%) |
| Interest Coverage Ratio: 6.19 > 6 (EBIT TTM 1.21b / Interest Expense TTM 196.0m) |
| A: 0.20 (Total Current Assets 7.53b - Total Current Liabilities 4.39b) / Total Assets 15.5b |
| B: 0.35 (Retained Earnings 5.48b / Total Assets 15.5b) |
| C: 0.08 (EBIT TTM 1.21b / Avg Total Assets 15.2b) |
| D: 0.47 (Book Value of Equity 4.88b / Total Liabilities 10.4b) |
| Altman-Z'' = 3.51 = A |
| DSRI: 1.02 (Receivables 2.83b/2.98b, Revenue 9.93b/10.7b) |
| GMI: 1.00 (GM 40.23% / 40.07%) |
| AQI: 0.91 (AQ_t 0.36 / AQ_t-1 0.40) |
| SGI: 0.93 (Revenue 9.93b / 10.7b) |
| TATA: -0.02 (NI 621.0m - CFO 956.0m) / TA 15.5b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of July 09, 2026, the stock is trading at EUR 57.34 with a total of 835,709 shares traded. Over the past week, the price has changed by -3.44%, over one month by +1.49%, over three months by +13.92% and over the past year by -1.80%.
Current recommended Stop Loss: 55.30 (which is 3.6% or 1.2 ATR below the current price).
Akzo Nobel has no consensus analysts rating.
P/E Trailing = 16.7956
P/E Forward = 16.8067
P/S = 1.0487
P/B = 2.1127
P/EG = 2.5098
Revenue TTM = 9.93b EUR
EBIT TTM = 1.21b EUR
EBITDA TTM = 1.59b EUR
Long Term Debt = 3.48b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.35b EUR (from shortTermDebt, last quarter)
Debt = 6.38b EUR (from shortLongTermDebtTotal, last quarter) + Leases 274.0m
Net Debt = 3.35b EUR (calculated: Debt 6.38b - CCE 3.03b)
Enterprise Value = 13.8b EUR (10.4b + Debt 6.38b - CCE 3.03b)
Interest Coverage Ratio = 6.19 (Ebit TTM 1.21b / Interest Expense TTM 196.0m)
EV/FCF = 20.86x (Enterprise Value 13.8b / FCF TTM 660.0m)
FCF Yield = 4.79% (FCF TTM 660.0m / Enterprise Value 13.8b)
FCF Margin = 6.65% (FCF TTM 660.0m / Revenue TTM 9.93b)
Net Margin = 6.25% (Net Income TTM 621.0m / Revenue TTM 9.93b)
Gross Margin = 40.07% ((Revenue TTM 9.93b - Cost of Revenue TTM 5.95b) / Revenue TTM)
Gross Margin QoQ = 40.99% (prev 39.46%)
Tobins Q-Ratio = 0.89 (Enterprise Value 13.8b / Total Assets 15.5b)
Interest Expense / Debt = 3.07% (Interest Expense 196.0m / Debt 6.38b)
Taxrate = 33.27% (325.0m / 977.0m)
NOPAT = 809.5m (EBIT 1.21b * (1 - 33.27%))
Current Ratio = 1.72 (Total Current Assets 7.53b / Total Current Liabilities 4.39b)
Debt / Equity = 1.31 (Debt 6.38b / totalStockholderEquity, last quarter 4.88b)
Debt / EBITDA = 2.11 (Net Debt 3.35b / EBITDA 1.59b)
Debt / FCF = 5.08 (Net Debt 3.35b / FCF TTM 660.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.09% (Net Income 621.0m / Total Assets 15.5b)
RoE = 14.08% (Net Income TTM 621.0m / Total Stockholder Equity 4.41b)
RoCE = 15.38% (EBIT 1.21b / Capital Employed (Equity 4.41b + L.T.Debt 3.48b))
RoIC = 6.77% (NOPAT 809.5m / Invested Capital 12.0b)
WACC = 5.50% (E(10.4b)/V(16.8b) * Re(7.61%) + D(6.38b)/V(16.8b) * Rd(3.07%) * (1-Tc(0.33)))
Discount Rate = 7.61% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 38.65 | Cagr: 0.16%
[DCF] Terminal Value 77.97% ; FCFF base≈554.0m ; Y1≈635.1m ; Y5≈934.7m
[DCF] Fair Price = 62.55 (EV 14.1b - Net Debt 3.35b = Equity 10.7b / Shares 171.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 76.52 | EPS CAGR: 12.06% | SUE: 0.43 | # QB: 0
Revenue Correlation: -84.20 | Revenue CAGR: -2.38% | SUE: 0.72 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.13 | Chg30d=+0.96% | Revisions=+0% | Analysts=4
EPS next Quarter (2026-09-30): EPS=1.04 | Chg30d=+6.80% | Revisions=+0% | Analysts=3
EPS current Year (2026-12-31): EPS=3.85 | Chg30d=+1.06% | Revisions=-22% | GrowthEPS=+6.2% | GrowthRev=-1.3%
EPS next Year (2027-12-31): EPS=4.27 | Chg30d=+0.89% | Revisions=-18% | GrowthEPS=+10.7% | GrowthRev=+2.5%
[Analyst] Revisions Ratio: -24% (up=5, down=9)